Effects of asbestos and smoking on the levels and rates of change of lung function in a crocidolite exposed cohort in Western Australia

被引:23
作者
Alfonso, HS
Fritschi, L
de Klerk, NH
Olsen, N
Sleith, J
Musk, AW
机构
[1] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia
[2] Sir Charles Gairdner Hosp, Dept Resp Med, Perth, WA, Australia
[3] Telethon Inst Child Hlth Res, Dept Biostat & Genet Epidemiol, Perth, WA, Australia
关键词
D O I
10.1136/thx.2004.022806
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Increased rates of death from asbestos related diseases have been reported in former workers and residents exposed to crocidolite (blue asbestos) at Wittenoom, Western Australia. Exposure to asbestos is associated with reduced static lung volumes, gas transfer and lung compliance, and a restrictive ventilatory abnormality. Methods: The effects of crocidolite exposure and smoking history on levels and rates of change of lung function were evaluated using a linear mixed model. Lung function was measured as forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), and FEV1/FVC. Results: Cumulative doses of asbestos and the presence of radiographic asbestosis were associated with lower levels of FEV1 and FVC and a steeper decline during the period of observation. Subjects exposed to asbestos at a younger age had lower levels of FEV1 and FVC. Current smokers had lower levels and a steeper decline in lung function than never smokers. No significant interactions between crocidolite exposure and smoking on the levels or rates of change of lung function were found. Conclusions: The deleterious effects of crocidolite exposure on lung function persist in this population, despite asbestos exposure having ceased more than 30 years ago. No significant interactions were found in this population between asbestos and smoking at the first visit or longitudinally.
引用
收藏
页码:1052 / 1056
页数:5
相关论文
共 37 条
[1]  
[Anonymous], 1987, Am Rev Respir Dis, V136, P1285
[2]  
[Anonymous], BLUE MURDER 2000 DOO
[3]   EFFECTS OF SMOKING INTERVENTION AND THE USE OF AN INHALED ANTICHOLINERGIC BRONCHODILATOR ON THE RATE OF DECLINE OF FEV(1) - THE LUNG HEALTH STUDY [J].
ANTHONISEN, NR ;
CONNETT, JE ;
KILEY, JP ;
ALTOSE, MD ;
BAILEY, WC ;
BUIST, AS ;
CONWAY, WA ;
ENRIGHT, PL ;
KANNER, RE ;
OHARA, P ;
OWENS, GR ;
SCANLON, PD ;
TASHKIN, DP ;
WISE, RA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (19) :1497-1505
[4]  
ARMSTRONG BK, 1988, BRIT J IND MED, V45, P5
[5]  
COOKSON W, 1986, AM REV RESPIR DIS, V133, P994
[6]  
COTES J, 1993, ASSESSMENT APPL MED
[7]  
de Klerk NH, 1998, INT J CANCER, V75, P362, DOI 10.1002/(SICI)1097-0215(19980130)75:3&lt
[8]  
362::AID-IJC6&gt
[9]  
3.0.CO
[10]  
2-0